Protein signatures associated with tumor cell dissemination in head and neck cancer

Journal of Proteomics

Volumn 74, Issue 4, 2011, Pages 558-566

  Bleijerveld, Onno B ^a   Brakenhoff, Ruud H ^c   Schaaij Visser, Tieneke B M ^a,b   Damen, J Mirjam A ^a,b   Altelaar, A F Maarten ^a,b   Heck, Albert J R ^a,b   Leemans, C René ^c   Slijper, Monique ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokeratin 19; Disseminated tumor cells; Head and neck squamous cell carcinoma; Two dimensional difference in gel electrophoresis

Indexed keywords

CYTOKERATIN 19;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BONE MARROW; CANCER CLASSIFICATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KERATIN-19; MALE; METABOLOME; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, SQUAMOUS CELL; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 79952241593     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.01.008     Document Type: Article

References (36)

1. Pisani P., Bray F., Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002, 97:72-81.
2. Polesel J., Talamini R., La Vecchia C., Levi F., Barzan L., Serraino D., et al. Tobacco smoking and the risk of upper aero-digestive tract cancers: a reanalysis of case-control studies using spline models. Int J Cancer 2008, 122:2398-2402.
3. Franceschi S., Levi F., La Vecchia C., Conti E., Dal Maso L., Barzan L., et al. Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer. Int J Cancer 1999, 83:1-4.
4. Braakhuis B.J., Snijders P.J., Keune W.J., Meijer C.J., Ruijter-Schippers H.J., Leemans C.R., et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004, 96:998-1006.
5. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720.
6. Braakhuis B.J.M., Senft A., de Bree R., de Vries J., Ylstra B., Cloos J., et al. Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma. J Clin Pathol 2006, 59:1254-1260.
7. Colnot D.R., Nieuwenhuis E.J., Kuik D.J., Leemans C.R., Dijkstra J., Snow G.B., et al. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients. Clin Cancer Res 2004, 10:7827-7833.
8. Leon X., Quer M., Orus C., del Prado Venegas M., Lopez M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 2000, 22:680-686.
9. Leemans C.R., Tiwari R., Nauta J.J., van der Waal I., Snow G.B. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993, 71:452-456.
10. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4:448-456.
11. Riethdorf S., Wikman H., Pantel K. Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008, 123:1991-2006.
12. Alix-Panabieres C., Muller V., Pantel K. Current status in human breast cancer micrometastasis. Curr Opin Oncol 2007, 19:558-563.
13. Pantel K., Brakenhoff R.H., Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008, 8:329-340.
14. Alix-Panabieres C., Riethdorf S., Pantel K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res 2008, 14:5013-5021.
15. Gath H.J., Heissler E., Hell B., Bier J., Riethmuller G., Pantel K. Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. Int J Oral Maxillofac Surg 1995, 24:351-355.
16. Wollenberg B., Ollesch A., Maag K., Funke I., Wilmes E. Micrometastases in bone marrow of patients with cancers in the head and neck area. Laryngorhinootologie 1994, 73:88-93.
17. Partridge M., Brakenhoff R., Phillips E., Ali K., Francis R., Hooper R., et al. Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin Cancer Res 2003, 9:5287-5294.
18. Schaaij-Visser T.B., Graveland A.P., Gauci S., Braakhuis B.J., Buijze M., Heck A.J., et al. Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res 2009, 15:7666-7675.
19. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856-2860.
20. Meiring H.D., van der Heeft E., ten Hove G.J., de Jong A.P.J.M. Nanoscale LC-MS(n): technical design and applications to peptide and protein analysis. J Sep Sci 2002, 25:557-568.
21. Boersema P.J., Raijmakers R., Lemeer S., Mohammed S., Heck A.J. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat Protoc 2009, 4:484-494.
22. Mortensen P., Gouw J.W., Olsen J.V., Ong S.E., Rigbolt K.T., Bunkenborg J., et al. MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. J Proteome Res 2010, 9:393-403.
23. Chuthapisith S., Layfield R., Kerr I.D., Hughes C., Eremin O. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int J Oncol 2007, 30:1545-1551.
24. Raijmakers R., Berkers C.R., de Jong A., Ovaa H., Heck A.J., Mohammed S. Automated online sequential isotope labeling for protein quantitation applied to proteasome tissue-specific diversity. Mol Cell Proteomics 2008, 7:1755-1762.
25. Boersema P.J., Aye T.T., van Veen T.A., Heck A.J., Mohammed S. Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates. Proteomics 2008, 8:4624-4632.
26. Woelfle U., Cloos J., Sauter G., Riethdorf L., Janicke F., van Diest P., et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 2003, 63:5679-5684.
27. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002, 419:624-629.
28. Kanaji N., Bandoh S., Fujita J., Ishii T., Ishida T., Kubo A. Compensation of type I and type II cytokeratin pools in lung cancer. Lung Cancer 2007, 55:295-302.
29. Lindberg K., Rheinwald J.G. Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 1989, 134:89-98.
30. Crowe D.L., Milo G.E., Shuler C.F. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 1999, 78:1256-1263.
31. Paccione R.J., Miyazaki H., Patel V., Waseem A., Gutkind J.S., Zehner Z.E., et al. Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility. Mol Cancer Ther 2008, 7:2894-2903.
32. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
33. Willipinski-Stapelfeldt B., Riethdorf S., Assmann V., Woelfle U., Rau T., Sauter G., et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 2005, 11:8006-8014.
34. Ceruse P., Rabilloud M., Charrie A., Dubreuil C., Disant F. Study of cyfra 21-1, a tumor marker, in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 2005, 114:768-776.
35. Sawant S.S., Zingde S.M., Vaidya M.M. Cytokeratin fragments in the serum: their utility for the management of oral cancer. Oral Oncol 2008, 44:722-732.
36. Zhong L.P., Zhu H.G., Zhang C.P., Chen W.T., Zhang Z.Y. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2007, 36:230-234.